Introduction: Maternal asymptomatic colonization with GBS
(Group-BStreptococcus)
has become a major cause of sepsis, meningitis and encephalopathy in neonates
alongside premature births, stillbirths and post-natal infections. Routine screening of pregnant women for GBS
carriage and antimicrobial susceptibility are therefore necessary. This
study was aimed at evaluating the prevalence,
antimicrobial susceptibility pattern and factors associated with GBS
colonization in pregnant women at the Regional Hospital Bamenda (RHB). MaterialsandMethods: Vaginal and rectal swab samples were collected from
121 pregnant women in the 3rd trimester at the RHB from December
2017 to May 2018. Sociodemographic, obstetric and neonatal history and some clinical parameters were obtained through
a questionnaire approach. Cultures for the isolation and identification
of GBS from the samples were done and grouping as well as susceptibility
testing of GBS isolates was done. Results: The colonisation rates were 5.8%
(7), 1.7% (2) and 5.8% (7) for rectal,
vaginal and concomitant recto-vaginal carriage. GBS was isolated in thevagina/rectum
of 16 participants (13.2% prevalence). Of the 16 GBS strains
References
[1]
Baker, C.J. and Barrett, F.F. (1973) Transmission of Group B Streptococci among Paturient Women and Their Neonates. Journal of Pediatrics, 83, 919-925.
https://doi.org/10.1016/S0022-3476(73)80524-4
[2]
You, D., Bastian, P., Wu, J. and Wardlaw, T., on Behalf of the United Nations Inter-Agency Group for Child Mortality Estimation (2013) Levels and Trends in Child Mortality. World Health Organization, Geneva.
http://www.who.int/maternal_child_adolescent/documents/levels_trends_child_mortality_2013/en/
[3]
United Nations (2017) The Sustainable Development Goals Report. United Nations, New York, 1-56.
https://unstats.un.org/sdgs/files/report/2017/TheSustainableDevelopmentGoalsReport2017.pdf
[4]
World Health Organization (2014) Neonatal Deaths-Cameroon Profile. World Health Organization, Geneva.
[5]
Edmond, K.M., Kortsalioudaki, C., Scott, S., Schrag, S.J., Zaidi, A.K., Cousens, S., et al. (2012) Group B Streptococcal Disease in Infants Aged Younger than 3 Months: Systematic Review and Meta-Analysis, The Lancet, 379, 547-556.
https://doi.org/10.1016/S0140-6736(11)61651-6
[6]
Verani, J.R., McGee, L. and Schrag, S.J. (2010) Prevention of Perinatal Group B Streptococcal Disease—Revised Guidelines from CDC, 2010. Morbidity and Mortality Weekly Report, 19, 1-36.
[7]
Chou, D., Daelmans, B., Jolivet, R.R., Kinney, M. and Say, L. (2015) Ending Preventable Maternal and Newborn Mortality and Stillbirths. BMJ, 351, Article No. h4255. https://doi.org/10.1136/bmj.h4255
[8]
Yücesoy, G., Çaliskan, E., Karadenizli, A., Çorakçi, A., Yücesoy, I. and Hüseyinoglu, N. (2004) Maternal Colonisation with Group B Streptococcus and Effectiveness of a Culture-Based Protocol to Prevent Early-Onset Neonatal Sepsis. International Journal of Clinical Practice, 58, 735-739.
https://doi.org/10.1111/j.1368-5031.2004.00025.x
[9]
Gavino, M. and Wang, E. (2007) A Comparison of a New Rapid Real Time Polymerase Chain Reaction System to Traditional Culture in Determining Group B Streptococcus Colonization. American Journal of Obstetrics and Gynecology, 197, 388.E1-388.E4. https://doi.org/10.1016/j.ajog.2007.06.016
[10]
Regan, J.A., Klebanoff, M.A. and Nugent, R.P. (1991) The Epidemiology of Group B Streptococcal Colonization in Pregnancy. Vaginal Infections and Prematurity Study Group. Obstetrics & Gynecology, 77, 604-610.
[11]
Persson, K., Bjerre, B., Hansson, H. and Forsgren, A. (1981) Several Factors Influencing the Colonization of Group B Streptococci—Rectum Probably the Main Reservoir. Scandinavian Journal of Infectious Diseases, 13, 171-175.
https://doi.org/10.3109/inf.1981.13.issue-3.03
http://www.ncbi.nlm.nih.gov/pubmed/6797054
[12]
Foxman, B., Gillespie, B.W., Manning, S.D. and Marrs, C.F. (2007) Risk Factors for Group B Streptococcal Colonization: Potential for Different Transmission Systems by Capsular Type. Annals of Epidemiology, 17, 854-862.
https://doi.org/10.1016/j.annepidem.2007.05.014
[13]
Kwatra, G., Cunnington, M.C., Merrall, E., Adrian P V., Ip, M., Klugman, K.P., et al. (2016) Prevalence of Maternal Colonisation with Group B Streptococcus: A Systematic Review and Meta-Analysis. The Lancet Infectious Diseases, 16, 1076-1084.
https://doi.org/10.1016/S1473-3099(16)30055-X
[14]
Foumane, P., Mboudou, E., Dohbit, J.S., Nkemayim, D.C., Tchokoteu, P.F. and Doh, A.S. (2009) Group B Beta Hemolytic Streptococcus in Pregnancy and Its Effect on Maternal and Foetal Outcome in the Yaounde Gene Hospital: A Descriptive Study. Clinics in Mother and Child Health, 6, 995-1002.
[15]
Adawaye, C., Michel, T., Paul, A.J., Hortense, G., Koanga, M. and Sinata, K.S. (2014) Vaginal Colonization and Resistance Profile of Group B Streptococcus among Pregnant Women in Yaound Gynecology, Obstetric and Pediatric Hospital in Cameroon. Journal of Clinical Medicine and Research, 6, 16-21.
[16]
Nizet, V. and Rubens, C.E. (2000) Pathogenic Mechanisms and Virulence Factors of Group B Streptococci. In: Fischetti, V.A., Novick, R.P., Ferretti, J.J., Portnoy, D.A. and Rood, J.I., Eds., Gram-Positive Pathogens, ASM Press, Washington DC.
https://doi.org/10.1128/9781555816513.ch13
[17]
American College of Obstetricians and Gynecologists (2011) Committee Opinion No. 485: Prevention of Early-Onset Group B Streptococcal Disease in Newborns. Obstetrics & Gynecology, 117, 1019-127.
https://doi.org/10.1097/AOG.0b013e318219229b
https://www.acog.org/Resources-AndPublications/Committee-Opinions/Committee-on-Obstetric-Practice/Prevention-of-EarlyOnset-Group-B-Streptococcal-Disease-in-Newborns
[18]
Centers for Disease Control and Prevention (2007) Perinatal Group B Streptococcal Disease after Universal Screening Recommendations—United States, 2003-2005. Morbidity and Mortality Weekly Report, 56, 701-705.
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5628a1.htm
[19]
Verani, J.R., McGee, L. and Schrag, S.J. (2010) Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC. Recommendations and Reports, 59, 1-32.
[20]
Rochetti, T., Marconi, C., Rall, V.L, Borges, V.T., Corrente, J.E. and da Silver, M.J. (2011) Group B Streptococci Colonization in Pregnant Women: Risk Factors and Evaluation of the Vaginal Flora. Archives of Gynecology and Obstetrics, 283, 717-721. https://doi.org/10.1007/s00404-010-1439-8
[21]
Schrag, S., Gorwitz, R., Fultz-Butts, K. and Schuchat, A. (2002) Prevention of Perinatal Group B Streptococcal Disease. Revised Guidelines from CDC. MMWR Recomm Rep, 51, 1-22.
[22]
Assefa, S., Desta, K. and Lema, T. (2018) Group B Streptococci Vaginal Colonization and Drug Susceptibility Pattern among Pregnant Women Attending in Selected Public Antenatal Care Centers in Addis. BMC Pregnancy and Childbirth, 18, Article No. 135. https://doi.org/10.1186/s12884-018-1791-4
[23]
World Health Organization (2016) United Nations High-Level Meeting on Antimicrobial Resistance. Antimicrobial Resistance. World Health Organization, Geneva, 3.
[24]
Turner, C., Turner, P., Po, L., Maner, N., De Zoysa, A., Afshar, B., et al. (2012) Group B Streptococcal Carriage, Serotype Distribution and Antibiotic Susceptibilities in Pregnant Women at the Time of Delivery in a Refugee Population on the Thai-Myanmar Border. BMC Infectious Diseases, 12, Article No. 34.
https://doi.org/10.1186/1471-2334-12-34
[25]
Mengist, A., Kannan, H. and Abdissa, A. (2016) Prevalence and Antimicrobial Susceptibility Pattern of Anorectal and Vaginal Group B Streptococci Isolates among Pregnant Women in Jimma, Ethiopia. BMC Research Notes, 9, Article No. 351.
https://doi.org/10.1186/s13104-016-2158-4
[26]
Mitima, K.T., Ntamako, S., Birindwa, A.M., Mukanire, N., Kivukuto, J.M. and Tsongo, K. (2014) Brief Original Article Prevalence of Colonization by Streptococcus agalactiae among Pregnant Women in Bukavu, Democratic Republic of the Congo. The Journal of Infection in Developing Countries, 8, 1195-1200.
https://doi.org/10.3855/jidc.5030
[27]
Bassir, A., Dhibou, H., Farah, M., Mohamed, L., Amal, A., Nabila, S., et al. (2016) Portage vaginal du streptocoque du groupe B chez la femme enceinte au niveau de la region de Marrakech. The Pan African Medical Journal, 23, Article No. 107.
https://doi.org/10.11604/pamj.2016.23.107.9047
[28]
Ezeonu, I.M. and Agbo, MC. (2014) Incidence and Anti-Microbial Resistance Profile of Group B Streptococcus (GBS) Infection in Pregnant women in Nsukka, Enugu State, Nigeria. African Journal of Microbiology Research, 8, 91-95.
https://doi.org/10.5897/AJMR12.2307
http://academicjournals.org/journal/AJMR/article-abstract/271798542418
[29]
Stoll, B.J. and Schuchat, A. (1998) Maternal Carriage of Group B Streptococci in Developing Countries. The Pediatric Infectious Disease Journal, 17, 499-503.
https://doi.org/10.1097/00006454-199806000-00013
[30]
Schuchat, A. and Wenger, J.D. (1994) Epidemiology of Group B Streptococcal Disease. Risk Factors, Prevention Strategies, and Vaccine Development. Epidemiologic Reviews, 16, 374-402. https://doi.org/10.1093/oxfordjournals.epirev.a036159
